Naloxone Available in One in Three Philadelphia Pharmacies
In chain stores, naloxone was more likely to be in stock and to be available without a prescription
American Society of Clinical Oncology, May 31-June 4
The 55th Annual Meeting of the American Society of Clinical Oncology The annual meeting of the American Society of Clinical Oncology was held...
ADA: Vitamin D Supplementation Does Not Lower T2DM Risk
No significant difference in risk for type 2 diabetes seen for those receiving vitamin D, placebo
Testicular Cancer Treatment Does Not Up Risk for Offspring Birth Defects
No increased risk seen at posttreatment in children of fathers with testicular germ-cell cancer
Dietary Supplements May Up Risk for Severe Medical Events
Increased risk seen in association with supplements sold for muscle building, energy, weight loss
ASCO: Enzalutamide Beneficial in Metastatic Prostate Cancer
Progression-free, overall survival longer for men with metastatic, hormone-sensitive prostate cancer
Emgality Receives First FDA Approval for Treating Cluster Headache
Patients treated with Emgality had 8.7 fewer cluster headache attacks at 3.0 weeks versus 5.2 with placebo
App Helps Pediatric Asthma Patients, Parents Self-Monitor
With one year of use, improvements seen in asthma outcomes
ASCO: Olaparib Beats Placebo for BRCA-Related Pancreatic Cancer
Progression-free survival significantly improved with olaparib versus placebo for metastatic disease
Common Supplement Ingredient Could Harm Fetus, FDA Warns
Vinpocetine is a man-made compound used in some products sold as dietary supplements
